trending Market Intelligence /marketintelligence/en/news-insights/trending/-Bmw2HgTt1HkZs4n792gxQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Terumo's device to treat brain aneurysms gets US FDA approval

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Terumo's device to treat brain aneurysms gets US FDA approval

The U.S. Food and Drug Administration gave pre-market approval to Terumo Corp.'s FRED system to treat brain aneurysms — a bulge in a blood vessel of the brain.

The Japanese medical-device maker's product is the first blood flow director in the U.S. that uses self-expanding braided nitinol mesh to help re-direct blood flow and promote blocking or closing of an aneurysm, Terumo said in a statement.

FRED, which stands for the flow re-direction endoluminal device, was approved in the EU in 2013 and has been used in nearly 20,000 procedures.